Deleterious effects of minocycline after in vivo target deprivation of thalamocortical neurons in the immature, metallothionein-deficient mouse brain

Journal of Neuroscience Research

Volumn 87, Issue 6, 2009, Pages 1356-1368

  Potter, Emily G ^a,b,d   Cheng, Ying ^a   Natale, Jo Anne E ^a,b,c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Metallothionein; Microglia; Minocycline; Traumatic brain injury

Indexed keywords

CALPAIN; CYTOKINE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH FACTOR; METALLOTHIONEIN; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; SODIUM CHLORIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; IFI1 PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; ENZYME PHOSPHORYLATION; GENE EXPRESSION; LATERAL GENICULATE NUCLEUS; MICROGLIA; MOUSE; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; THALAMOCORTICAL TRACT; VISUAL CORTEX; ANIMAL; BRAIN; BRAIN CORTEX; BRAIN INJURY; DRUG EFFECT; GENETICS; GENICULATE BODY; METABOLISM; MOUSE MUTANT; NERVE CELL; NERVE TRACT; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; THALAMUS;

ANIMALS; BRAIN; BRAIN INJURIES; CALPAIN; CELL SURVIVAL; CEREBRAL CORTEX; GENE EXPRESSION; GENICULATE BODIES; GTP-BINDING PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; METALLOTHIONEIN; MICE; MICE, KNOCKOUT; MICROGLIA; MINOCYCLINE; NEURAL PATHWAYS; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; THALAMUS;

EID: 65549090117     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21963     Document Type: Article

References (67)

1. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM. 2002. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52:54-61.
2. Bantubungi K, Jacquard C, Greco A, Pintor A, Chtarto A, Tai K, Galas MC, Tenenbaum L, Deglon N, Popoli P, Minghetti L, Brouillet E, Brotchi J, Levivier M, Schiffmann SN, Blum D. 2005. Minocycline in phenotypic models of Huntington's disease. Neurobiol Dis 18:206-217.
3. Bizat N, Hermel JM, Boyer F, Jacquard C, Creminon C, Ouary S, Escartin C, Hantraye P, Kajewski S, Brouillet E. 2003. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. J Neurosci 23:5020-5030.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Butler TL, Pennypacker KR. 2004. Temporal and regional expression of Fos-related proteins in response to ischemic injury. Brain Res Bull 63:65-73.
6. Butler TL, Pennypacker KR. 2005. The transcriptional response to hypoxic insult controlled by FRA-2. Gene Expr 12:61-67.
7. Bye N, Habgood MD, Callaway JK, Malakooti N, Potter A, Kossmann T, Morganti-Kossmann MC. 2006. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol.
8. Dailey ME, Waite M. 1999. Confocal imaging of microglial cell dynamics in hippocampal slice cultures. Methods 18:222-230.
9. Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F. 2004. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 19:3266-3276.
10. Domercq M, Matute C. 2004. Neuroprotection by tetracyclines. Trends Pharmacol Sci 25:609-612.
11. Dommergues MA, Plaisant F, Verney C, Gressens P. 2003. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 121:619-628.
12. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM. 2001. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A 98:14669-14674.
13. Fan LW, Pang Y, Lin S, Rhodes PG, Cai Z. 2005a. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 133:159-168.
14. Fan LW, Pang Y, Lin S, Tien LT, Ma T, Rhodes PG, Cai Z. 2005b. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res 82:71-82.
15. Fendrick SE, Miller KR, Streit WJ. 2005. Minocycline does not inhibit microglia proliferation or neuronal regeneration in the facial nucleus following crush injury. Neurosci Lett 385:220-223.
16. Fox C, Dingman A, Derugin N, Wendland MF, Manabat C, Ji S, Ferriero DM, Vexler ZS. 2005. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 25:1138-1149.
17. Giralt M, Penkowa M, Lago N, Molinero A, Hidalgo J. 2002. Metallothionein-112 protect the CNS after a focal brain injury. Exp Neurol 173:114-128.
18. Heo K, Cho YJ, Cho KJ, Kim HW, Kim HJ, Shin HY, Lee BI, Kim GW. 2006. Minocycline inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after treatment with kainic acid in mice. Neurosci Lett 398:195-200.
19. Ito D, Tanaka K, Suzuki S, Dembo T, Fukuuchi Y. 2001. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 32:1208-1215.
20. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
21. Lee SM, Yune TY, Kim SJ, Park DW, Lee YK, Kim YC, Oh YJ, Markelonis GJ, Oh TH. 2003. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma 20:1017-1027.
22. Lee HK, Choi SS, Han KJ, Han EJ, Suh HW. 2004. Roles of adenosine receptors in the regulation of kainic acid-induced neurotoxic responses in mice. Brain Res Mol Brain Res 125:76-85.
23. Lin S, Zhang Y, Dodel R, Farlow MR, Paul SM, Du Y. 2001. Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons. Neurosci Lett 315:61-64.
24. Liu MC, Akle V, Zheng W, Dave JR, Tortella FC, Hayes RL, Wang KK. 2006. Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem J 394(Pt 3):715-725.
25. Milligan CE, Levitt P, Cunningham TJ. 1991. Brain macrophages and microglia respond differently to lesions of the developing and adult visual system. J Comp Neurol 314:136-146.
26. Morimoto N, Shimazawa M, Yamashima T, Nagai H, Hara H. 2005. Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage. Brain Res 1044:8-15.
27. Muessel MJ, Klein RM, Wilson AM, Berman NE. 2002. Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules. Brain Res Mol Brain Res 103:12-27.
28. Natale JE, Cheng Y, Martin LJ. 2002. Thalamic neuron apoptosis emerges rapidly after cortical damage in immature mice. Neuroscience 112:665-676.
29. Natale JE, Knight JB, Cheng Y, Rome JE, Gallo V. 2004. Metallothionein I and II mitigate age-dependent secondary brain injury. J Neurosci Res 78:303-314.
30. O'Reilly LA, Print C, Hausmann G, Moriishi K, Cory S, Huang DC, Strasser A. 2001. Tissue expression and subcellular localization of the pro-survival molecule Bcl-w. Cell Death Differ 8:486-494.
31. Park SK, Kim J, Seomun Y, Choi J, Kim DH, Han IO, Lee EH, Chung SK, Joo CK. 2001. Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem Biophys Res Commun 284:966-971.
32. Penkowa M, Espejo C, Martinez-Caceres EM, Poulsen CB, Montalban X, Hidalgo J. 2001. Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis. J Neuroimmunol 119:248-260.
33. Penkowa M, Florit S, Giralt M, Quintana A, Molinero A, Carrasco J, Hidalgo J. 2005. Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res 79:522-534.
34. Pennypacker KR, Yang X, Gordon MN, Benkovic S, Miller D, O'Callaghan JP. 2000. Long-term induction of Fos-related antigen-2 after methamphetamine-, methylenedioxymethamphetamine-, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and trimethyltin-induced brain injury. Neuroscience 101:913-919.
35. Pi R, Li W, Lee NT, Chan HH, Pu Y, Chan LN, Sucher NJ, Chang DC, Li M, Han Y. 2004. Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways. J Neurochem 91:1219-1230.
36. Potter EG, Cheng Y, Knight JB, Gordish-Dressman H, Natale JE. 2007. Metallothionein I and II attenuate the thalamic microglial response following traumatic axotomy in the immature brain. J Neurotrauma 24:28-42.
37. Potts MB, Koh SE, Whetstone WD, Walker BA, Yoneyama T, Claus CP, Manvelyan HM, Noble-Haeusslein LJ. 2006. Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets. NeuroRx 3:143-153.
38. Raghupathi R. 2004. Cell death mechanisms following traumatic brain injury. Brain Pathol 14:215-222.
39. Ray SK, Dixon CE, Banik NL. 2002. Molecular mechanisms in the pathogenesis of traumatic brain injury. Histol Histopathol 17:1137-1152.
40. Repici M, Atzori C, Migheli A, Vercelli A. 2003. Molecular mechanisms of neuronal death in the dorsal lateral geniculate nucleus following visual cortical lesions. Neuroscience 117:859-867.
41. Ringger NC, O'Steen BE, Brabham JG, Silver X, Pineda J, Wang KK, Hayes RL, Papa L. 2004. A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. J Neurotrauma 21: 1443-1456.
42. Robertson CL. 2004. Mitochondrial dysfunction contributes to cell death following traumatic brain injury in adult and immature animals. J Bioenerg Biomembr 36:363-368.
43. Robertson CL, Soane L, Siegel ZT, Fiskum G. 2006. The potential role of mitochondria in pediatric traumatic brain injury. Dev Neurosci 28:432-446.
44. Saccani S, Pantano S, Natoli G. 2002. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 3:69-75.
45. Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. 2001. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48:1393-1399.
46. Schwab JM, Beschorner R, Nguyen TD, Meyermann R, Schluesener HJ. 2001. Differential cellular accumulation of connective tissue growth factor defines a subset of reactive astrocytes, invading fibroblasts, and endothelial cells following central nervous system injury in rats and humans. J Neurotrauma 18:377-388.
47. Seo J, Gordish-Dressman H, Hoffman EP. 2006. An interactive power analysis tool for microarray hypothesis testing and generation. Bioinformatics 22:808-814.
48. Stirling DP, Khodarahmi K, Liu J, McPhail LT, McBride CB, Steeves JD, Ramer MS, Tetzlaff W. 2004. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 24:2182-2190.
49. Streit WJ, Walter SA, Pennell NA. 1999. Reactive microgliosis. Prog Neurobiol 57:563-581.
50. Suk K. 2004. Minocycline suppresses hypoxic activation of rodent microglia in culture. Neurosci Lett 366:167-171.
51. Takekawa M, Saito H. 1998. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95:521-530.
52. Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, Woodard EJ, Snyder EY, Eichler ME, Friedlander RM. 2004. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci U S A 101:3071-3076.
53. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. 2001. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580-2588.
54. Tikka TM, Koistinaho JE. 2001. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166:7527-7533.
55. Tsuji M, Wilson MA, Lange MS, Johnston MV. 2004. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 189:58-65.
56. Tumor Analysis Best Practices Working Group. 2004. Expression profiling - best practices for data generation and interpretation in clinical trials. Nat Rev Genet 5:229-237.
57. Wang CX, Yang T, Shuaib A. 2003a. Effects of minocycline alone and in combination with mild hypothermia in embolic stroke. Brain Res 963:327-329.
58. Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM. 2003b. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci U S A 100: 10483-10487.
59. Wang J, Wei Q, Wang CY, Hill WD, Hess DC, Dong Z. 2004. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279:19948-19954.
60. Wei X, Zhao L, Liu J, Dodel RC, Farlow MR, Du Y. 2005. Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Neuroscience 131: 513-521.
61. West MJ, Slomianka L, Gundersen HJ. 1991. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482-497.
62. West MJ, Ostergaard K, Andreassen OA, Finsen B. 1996. Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol 370:11-22.
63. Xie Z, Smith CJ, Van Eldik LJ. 2004. Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38. Glia 45:170-179.
64. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 95:15769-15774.
65. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 96:13496-13500.
66. Zemke D, Majid A. 2004. The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol 27:293-298.
67. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, Gullans S, Ferrante RJ, Przedborski S, Kristal BS, Friedlander RM. 2002. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417(6884):74-78.